Terazosin
- Product NDC
- 70518-3114
- 11-digit product format
- 705183114
- Labeler code
- 70518
- Product ID
- 70518-3114_c4555e92-e10c-9e80-e053-2a95a90ae7fc
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Terazosin Hydrochloride
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- REMEDYREPACK INC.
- Application
- ANDA075317
- Marketing category
- ANDA
- Marketing start
- 2021-06-08
- Marketing end
- 0000-00-00
- Substance
- TERAZOSIN HYDROCHLORIDE
- Active strength
- 10 mg/1
- Pharmacologic classes
- Adrenergic alpha-Antagonists [MoA],alpha-Adrenergic Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70518-3114-0 | 70518311400 | 90 CAPSULE in 1 BOTTLE, PLASTIC (70518-3114-0) | 90 capsule | 2021-06-08 | 0000-00-00 | No | No | Current |